Ruka Yoshida

9PUBLICATIONS
40CO-AUTHORS
PharmacogenomicsCardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)Medical biotechnology diagnostics (incl. biosensors)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 18, 2026
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki

|May 14, 2025
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial.

Tetsuya Ishikawa, Masahiro Natsuaki, Hirotoshi Watanabe

|Aug 31, 2024
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial.

Hirotoshi Watanabe, Masahiro Natsuaki, Takeshi Morimoto

|Nov 23, 2023
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.

Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto

|Aug 01, 2022
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort.

Yuki Obayashi, Hirotoshi Watanabe, Takeshi Morimoto

Pageof 2